Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
asthma
Pharma
AZ looks to grow Airsupra's reach with new asthma data
AZ showed that use of inhaler Airsupra in those with mild asthma reduced the risk of severe exacerbations by 47% compared to albuterol.
Kevin Dunleavy
May 19, 2025 12:15pm
AZ's Breztri set up for label expansion with 2 asthma trial wins
May 2, 2025 11:30am
AstraZeneca embraces pickleball craze with Fasenra sponsorship
Mar 13, 2025 4:05pm
Amgen, AZ's Tezspire excels in phase 3 rhinosinusitis trial
Nov 8, 2024 3:31pm
AZ pads data package for Airsupra in patients with milder asthma
Oct 7, 2024 2:40pm
In battle with GSK's Nucala, AZ's Fasenra wins FDA nod for EGPA
Sep 18, 2024 11:46am
